Biogen Shares Soar on News of Potential Merck, Allergan Takeover

Share This Article
August 2, 2016 4:10pm NASDAQ:BIIB

hotandhigherAccording to a Wall Street Journal report, Biogen Inc. (NASDAQ:BIIB) is attracting serious takeover interest from mega cap pharma rivals Merck (NYSE:MRK) and Allergan (NASDAQ:AGN).


From the report (emphasis mine):

Biotechnology giant Biogen Inc. has drawn takeover interest from drug companies including Merck & Co. and Allergan PLC, raising the possibility of another huge deal in the health-care industry.

Merck and Allergan have each sounded out Biogen on the possibility of a takeover, people familiar with the matter said. The communications were informal and preliminary, and they may not result in a deal—in part because Biogen may not be interested, they added.

Biogen had a market value of $68 billion on Tuesday afternoon. It isn’t clear whether other large drug companies also are contemplating a purchase of the company, which is in the process of searching for a new chief executive.

Who are these companies kidding? Of course Biogen is interested in a takeover deal. The biotech space is always a red hot with M&A activity, and BIIB has a duty to its shareholders to pursue a deal if the price is right.

Biogen closed up $28.28 (+9.37%) on the day at $330.11. Both Merck and Allergan shares fell on the news, down 0.56% and 1.51%, respectively. Biogen’s huge move was enough to spike the IBB by nearly 2.5%.

BIIB-2016-08-02


9 "BUY THE DIP" Growth Stocks For 2020

Read Next



Free Investing Ideas Newsletter!

Join over 70,000 investors who get the latest insights and top rated picks from our free investment newsletter.

Most Popular



7 Best ETFs for the NEXT Bull Market

Explore More from ETFDailyNews.com

Free Investment Newsletter

Join over 70,000 investors who get the latest insights and top rated picks from our free investment newsletter.

ETFDailyNews.com respects your privacy.

Best ETFs

We've rated and ranked nearly 2,000 ETFs and ETNs using our proprietary SMART Grade system.

View Top Rated ETFs

Best Categories

We've ranked dozens of ETF categories based on relative performance.

Best ETF Categories